Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies

Journal of Clinical Oncology

Volumn 15, Issue 4, 1997, Pages 1608-1616

  Pavletic, Z Steven ^a   Bishop, Michael R ^a   Tarantolo, Stefano R ^a   Martin Algarra, Salvador ^a   Bierman, Philip J ^a   Vose, Julie M ^a   Reed, Elizabeth C ^a   Gross, Thomas G ^a   Kollath, Jeff ^a   Nasrati, Khalliq ^a   Jackson, John D ^a   Armitage, James O ^a   Kessinger, Anne ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER GRADING; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GM; CRYOPRESERVATION; EARLY DIAGNOSIS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HLA SYSTEM; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE TRANSFUSION;

EID: 0030897496     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.4.1608     Document Type: Article

References (36)

1. Kessinger A, Smith DM, Strandjord SE, et al: Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 4:643-646, 1989
2. Schmitz N, Dreger P, Suttorp M, et al: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666-1672, 1995
3. Körbling M, Przepiorka D, Huh YO, et al: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659-1665, 1995
4. + Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 86:2842-2848, 1995
5. Bensinger WI, Weaver CH, Appelbaum FR, et al: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655-1658, 1995
6. Schmitz N, Bacigalupo A, Labopin M, et al: Transplantation of allogeneic peripheral blood progenitor cells - The EBMT experience. Bone Marrow Transplant 17:40-46, 1996 (suppl 2)
7. Korbling M, Fliedner TM: The evolution of clinical peripheral blood stem cell transplantation. Bone Marrow Transplant 17:4-11, 1996 (suppl 2)
8. Sheridan WP, Begley CG, Juttner CA, et al: Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640-644, 1992
9. Beyer J, Schwella N, Zigsem J, et al: Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: A randomized comparison. J Clin Oncol 13:1328-1335, 1995
10. Schmitz N, Linch DC, Dreger P, et al: Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet 347:353-357, 1996
11. Russell JA, Brown C, Bowen T et al. Allogeneic blood cell transplants for haematological malignancy: Preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 17:703-708, 1996
12. Bensinger WI, Clift R, Martin P, et al: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation. Blood 88:2794-2800, 1996
13. Azevedo WM, Aranha FJP, Gouvea JV, et al: Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies. Bone Marrow Transplant 16:647-653, 1995
14. Rosenfeld C, Collins R, Piñeiro L, et al: Allogeneic blood cell transplantation without posttransplant colony-stimulating factor in patients with hematopoietic neoplasm: A phase II study. J Clin Oncol 14:1314-1319, 1996
15. Storb R, Deeg JH, Whitehead J, et al: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729-735, 1986
16. Chao NJ, Schmidt GM, Niland JC, et al: Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 329:1225-1230, 1993
17. Hägglund H, Boström L, Remberger M, et al: Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients. Bone Marrow Transplant 16:747-753, 1995
18. Nemunaitis J, Buckner CD, Appelbaum FR, et al: Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor following allogeneic bone marrow transplantation. Blood 77:2065-2071, 1991
19. Schriber JR, Chao NJ, long GD, et al: Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation. Blood 84:1680-1684, 1994
20. Martin-Algarra S, Bishop MR, Tarantolo S, et al: Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis. Exp Hematol 23:1503-1508, 1995
21. Verbik DJ, Jackson JD, Pirruccello SJ, et al: Functional and phenotypic characterization of human peripheral blood stem cell harvests: A comparative analysis of cells from consecutive collections. Blood 85:1964-1970, 1995
22. Bishop MR, Tarantolo SR, Schmit-Pokorny K, et al: Mobilization of blood stem cells from HLA-matched related donors with low-dose granulocyte colony-stimulating factor for allogeneic transplantation. Blood 86:463a, 1995 (suppl 1, abstr 1840)
23. Kessinger A, O'Kane-Murphy B, Jackson J, et al: A comparison of different cryomedia and methods of freezing human hematopoietic stem cells obtained from bone marrow and peripheral blood for storage. Int J Cell Cloning 10:88-91, 1992 (suppl 1)
24. Giralt SA, LeMaistre CF, Vriesendorp HM, et al: Etoposide, cyclophosphamide, total-body-irradiation, and allogeneic bone marrow transplantation for hematologic malignancies. J Clin Oncol 12:1923-1930, 1994
25. Tarantolo SR, Walters T, Reed EC, et al: Cytomegalovirus surveillance and infection an allogeneic bone marrow and blood stem cell transplants. Blood 86:215a, 1995 (suppl 1, abstr 848)
26. Bishop MR, Anderson JR, Jackson JD, et al: High-dose therapy and peripheral blood progenitor cell transplantation: Effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood 83:610-616, 1994
27. Sullivan KM: Graft-versus-host disease, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell, 1994, pp 339-362
28. Eilers J, Berger AM, Petersen MC, et al: Development testing, and application of the oral assessment guide. Oncol Nurs Forum 15:325-330, 1988
29. Pavletic ZS, Bishop MR, Tarantolo S, et al: Immunological recovery following allogeneic transplantation with peripheral blood stem cells. Blood 86:104a, 1995 (suppl 1, abstr 403)
30. Spitzer G, Adkins DR, Spencer V, et al: Randomized study of growth factors post-peripheral-blood stem-cell transplant: Neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 12:661-670, 1994
31. Klumpp TR, Mangan KF, Goldberg SL, et al: Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem cell transplantation: A prospective, randomized trial. J Clin Oncol 13:1323-1327, 1995
32. Cortelazzo S, Viera P, Bellavita P, et al: Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin's lymphoma. J Clin Oncol 13: 935-941, 1995
33. Tarantolo SR, Haire WD, Stephens LC, et al: Platelet transfusions during hematopoietic stem cell transplantation correlate with organ dysfunction. Blood 84:488a, 1994, (suppl 1, abstr 1938)
34. Talmadge JE, Reed EC, Kessinger A, et al: Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant 17:101-109, 1996
35. Kitabayashi A, Hirokawa M, Hatano Y, et al: Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-alpha production. Blood 86:2220-2227, 1995
36. Majolino I, Saglio G, Scime R, et al: High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 17:555-560, 1996